
Xomore T 500mg/62.5mg Injection
Marketer
Morecare Pharmatec Pvt Ltd
Salt Composition
Ceftriaxone (500mg) + Tazobactum (62.5mg)
Overview Xomore T 500mg/62.5mg Injection
Combiflox 500mg/62.5mg Injection, a dual-action medication, combats diverse bacterial infections. Its mechanism inhibits microbial proliferation, thus curbing infection spread. Administration must be solely under a physician's guidance. Consistent adherence to the prescribed schedule is crucial; completing the entire course is vital, regardless of symptom improvement. Premature cessation may compromise efficacy. Typical mild adverse reactions encompass nausea, vomiting, diarrhea, and dyspepsia. Escalation of any side effect necessitates immediate medical consultation. Seek immediate medical attention for allergic responses (skin rashes, pruritus, edema, respiratory distress). Inform your doctor of all concurrent medications before commencing treatment. Pregnant or lactating individuals require prior physician approval. Alcohol consumption should be avoided due to potential increased drowsiness. While generally non-impairing to driving ability, refrain from driving if drowsiness or dizziness occurs. Adequate rest, balanced nutrition, and ample hydration contribute to quicker recovery. Monitoring treatment efficacy may involve periodic laboratory and diagnostic assessments by your doctor.
Primary Ingredients of Xomore T 500mg/62.5mg Injection
No text provided. Please provide the text you wish me to rewrite.
Uses of Xomore T 500mg/62.5mg Injection
Infections caused by bacteria
Major Benefits of Xomore T 500mg/62.5mg Injection:
This medication will be administered by your healthcare provider. Self-medication is strictly prohibited.
Common Side effects of Xomore T 500mg/62.5mg Injection:
- Diarrhea
- Increased liver enzymes
- Allergic reaction
- Rash
How to use Xomore T 500mg/62.5mg Injection:
This medication will be administered by your healthcare provider. Self-medication is strongly discouraged.
How Xomore T 500mg/62.5mg Injection works:
Xomore T Injection, containing 500mg Ceftriaxone and 62.5mg Tazobactum, employs a dual-action approach to combat bacterial infections. Ceftriaxone, a crucial antibiotic, disrupts bacterial cell wall synthesis, hindering their ability to thrive. The inclusion of Tazobactum, a beta-lactamase inhibitor, counteracts bacterial resistance mechanisms, optimizing Ceftriaxone's effectiveness.
SAFETY ADVICE
AlcoholSAFE
Concurrent use of alcohol and Xomore T 500mg/62.5mg Injection poses no known adverse reactions.
PregnancySAFE IF PRESCRIBED
Xomore T 500mg/62.5mg injections are typically deemed safe for use during gestation. Preclinical trials in animals have revealed minimal or no negative impacts on fetal development; nevertheless, clinical data from human trials are scarce.
Breast feedingCAUTION
Administering Xomore T 500mg/62.5mg Injection to breastfeeding mothers requires careful consideration. Discontinue breastfeeding throughout the mother's treatment course and until the medication is fully cleared from her system.
DrivingUNSAFE
Administration of Xomore T 500mg/62.5mg Injection can lead to reduced awareness, visual impairment, drowsiness, and dizziness. Driving should be avoided if these effects are experienced.
KidneyCONSULT YOUR DOCTOR
Insufficient data exists regarding the administration of Xomore T 500mg/62.5mg Injection to individuals with renal impairment. Physician consultation is advised.
LiverCAUTION
The injectable medication, Xomore T 500mg/62.5mg, requires careful administration to individuals with significant hepatic impairment. Dosage modification for Xomore T 500mg/62.5mg Injection may be necessary; physician consultation is advised. Altering the dosage of Xomore T 500mg/62.5mg Injection is not suggested for patients exhibiting mild or moderate liver dysfunction.
What if you forget to take Xomore T 500mg/62.5mg Injection :
Should you forget a scheduled dose of Xomore T 500mg/62.5mg Injection, seek advice from your physician.
Facts to Know About Xomore T 500mg/62.5mg Injection
| Label | Value |
|---|---|
| Developing Habits | No. |
| Treatment Category | Antimicrobials |
